FibroBiologics, Inc. Common Stock (FBLG) Earnings Analysis
FibroBiologics, Inc. Common Stock (FBLG) next reports earnings on 2026-07-30, consensus EPS -0.93 USD. Last quarter (2026-04-30) it missed with EPS -1.33 USD vs -1.26 USD est (-5.6%). It has beaten estimates in 1/4 recent quarters (25%). Trailing P/E -0.09.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does FBLG next report earnings?
| Next earnings date | 2026-07-30 |
|---|---|
| Consensus EPS estimate | -0.93 USD |
| Revenue estimate | n/a |
FBLG earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-04-30 | -1.33 USD | -1.26 USD | -5.6% | Miss |
| 2025-10-31 | -0.13 USD | -0.1 USD | -30% | Miss |
| 2025-07-31 | -0.12 USD | -0.11 USD | -9.1% | Miss |
| 2025-03-31 | -0.09 USD | -0.1 USD | +10% | Beat |
Beat rate: 1/4 (25%) over reported quarters with consensus data.
FBLG valuation and analyst view
| Trailing P/E | -0.09 |
|---|---|
| Trailing EPS | -8.36533 USD |
| Price / book | 0.64 |
| Dividend yield | 0.00% |
| Market cap | 0.00B |
| Analyst consensus | Buy (2 buy / 2 hold / 0 sell) |
Related research pages
Frequently asked questions
When is FibroBiologics, Inc. Common Stock (FBLG)'s next earnings date?
FibroBiologics, Inc. Common Stock is next scheduled to report on 2026-07-30, with a consensus EPS estimate of -0.93 USD.
Did FBLG beat earnings last quarter?
In its 2026-04-30 report, FBLG posted EPS of -1.33 USD versus a -1.26 USD estimate — a miss of 5.6%.
What is FBLG's earnings track record?
Over the last 4 reported quarters with consensus data, FBLG beat estimates 1 times (25%).
What is FBLG's current P/E ratio and EPS?
FBLG trades at a trailing P/E of -0.09 on trailing EPS of -8.365330273807828 USD.
What do analysts rate FBLG?
Analyst consensus is "Buy" across 4 ratings (0 strong buy, 2 buy, 2 hold, 0 sell, 0 strong sell).